Hip Replacement Implants Market Size, Share, Forecast To 2034

The g lobal hip replacement implants market size was estimated at USD 4.37 billion in 2025 and is anticipated to grow till USD 5.36 billion by 2034 , growing at a CAGR of 2.35% from 2026 to 2034.

The market growth is primarily attributed to the increasing prevalence of osteoarthritis and hip fractures, rising geriatric population, advancements in implant materials and design, and growing adoption of minimally invasive and robotic-assisted surgical techniques.

Market Dynamics Rising Aging Population Driving Demand for Hip Replacement Implants

The rising global aging population is fueling demand for hip replacement implants, as the older population is increasingly prone to osteoarthritis, osteoporosis, and hip fractures.

• For example, in 2024, as per Statistics Korea, the elderly population of Korea accounts for 19.2% of the total population.

Such a demographic shift is driving a growing need for surgical interventions to restore mobility and improve quality of life.

Development of a "smart" trial liner for hip replacement surgeries presents a significant market opportunity.

• For instance, in September 2024, as per the NIHR Cambridge Biomedical Research Centre, the University of Cambridge team developed a smart trial liner designed specifically for hip implants, embedded with microfluidic sensors that measure forces passing through the joint. The sensors help the surgeon assess and balance the soft tissues, which aids in the accurate positioning of the implant.

This real-time feedback enhances implant longevity, reduces complications, and improves overall patient outcomes.

Key Highlights

• By Procedure , the market is segmented into total hip replacement implants, partial femoral head, hip resurfacing, and revision hip. The Total hip replacement implants segment dominated the market in 2025 with a revenue share of 39.60%. This growth is attributed to the increasing prevalence of osteoarthritis, hip fractures, and other degenerative joint conditions, which drives the demand for comprehensive hip replacement procedures.
• By Material , the market is categorized into metal-on-metal, metal-on-polyethylene, ceramic-on-metal, ceramic-on-polyethylene, and ceramic-on-ceramic. The Ceramic on polyethylene segment is estimated to grow at the fastest pace with a CAGR of 3.32%, owing to its superior wear resistance, lower risk of osteolysis, and improved long-term durability, making it a preferred choice among orthopedic surgeons and patients.
• By End User, the market is categorized into hospitals & surgery centers, orthopedic clinics and others. The Hospitals & Surgery centers segment dominated the market in 2025. The growth is attributed to the availability of advanced surgical facilities and the presence of skilled orthopedic surgeons capable of performing high-volume hip replacement surgeries.
• Asia Pacific is estimated to be the fastest-growing region in the global market, with a CAGR of 4.35%. This growth is attributed to increasing prevalence of osteoarthritis and hip-related disorders, rising healthcare infrastructure investments, growing awareness of advanced orthopedic treatments, and an expanding geriatric population driving demand for hip replacement procedures.

MatOrtho Limited, Smith+Nephew, OMNIlife Science, Inc., MicroPort Scientific Corporation, Exactech, Inc., Zimmer Biomet, Medical Device Business Services, Inc., Stryker, Braun Melsungen AG, Enovis Corporation, Aesculap, Inc., Greens Surgicals Pvt. Ltd., NRV OrthoTech Pvt Ltd, HCM ORTHOCARE PVT, Sharma Orthopedic.

• In November 2024, CytexOrtho received approval from U.S. FDA to begin a first-in-human clinical study to evaluate the safety and efficacy of its ReNew Hip Implant cartilage repair technology.